Dr. Peter Yau, MD

Dr. Yau practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Yau's NPI, 1790954758, was assigned on February 25, 2008. Dr. Yau graduated from American University of the Caribbean School of Medicine in 2002. Dr. Yau holds Texas license N2348.

Dr. Yau's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Yau's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Yau is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Yau to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yau practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Yau's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Yau is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Yau's licenses on file in 2 states: Texas and California.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Yau treats.

CMS data shows 560 Medicare services from Dr. Yau across 9 procedure codes in 2024, for 301 Medicare patients. Medicare paid $52,590 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 301 Medicare patients who saw Dr. Yau in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yau's median patient age at 72, with 56% women.

In 2024, Dr. Yau wrote 1,467 Medicare Part D claims for 148 patients. 46% of them were for generic drugs. CMS names the drug for 1,288 of them, across 32 drugs with 11 or more claims each, at $9,124,556 in total drug cost. In 2023, CMS named 1,103 claims across 25 drugs.

Dr. Yau accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yau as offering telehealth.

Dmand AI links 26 papers to Dr. Yau, published from 2011 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Amino Acid Sequence, Disease Models, Animal and Liver. Dr. Yau has published most often in Nat Commun. Dr. Yau's most frequent co-authors are Xia Wu, MD, Alejandro C. Arroliga, MD and William James Bruce, MD.

Dmand AI links Dr. Yau to 2 clinical trials. Conditions studied include Emphysema, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 97 general payments to Dr. Yau from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $59,659.

Dr. Yau graduated from American University of the Caribbean School of Medicine in 2002.

Dr. Yau is in network with 16 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.